Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction.
about
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction.Sensitivity to imatinib of KCL22 chronic myeloid leukemia cell survival/growth and stem cell potential under glucose shortage
P2860
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Different BCR/Abl protein supp ...... ptation to energy restriction.
@en
Different BCR/Abl protein supp ...... ptation to energy restriction.
@nl
type
label
Different BCR/Abl protein supp ...... ptation to energy restriction.
@en
Different BCR/Abl protein supp ...... ptation to energy restriction.
@nl
prefLabel
Different BCR/Abl protein supp ...... ptation to energy restriction.
@en
Different BCR/Abl protein supp ...... ptation to energy restriction.
@nl
P2093
P2860
P50
P356
P1433
P1476
Different BCR/Abl protein supp ...... ptation to energy restriction.
@en
P2093
Federico Di Gesualdo
Maria Grazia Cipolleschi
Persio Dello Sbarba
Silvia Bono
P2860
P304
84810-84825
P356
10.18632/ONCOTARGET.13319
P407
P577
2016-11-12T00:00:00Z